AZGP1 and posterior cortical atrophy: AZGP1 significantly improved the prediction of PCa in a cohort of candidates for a prostatic biopsy, using isobaric stable isotope labeling and 2D-LC-MS/MS as the discovery method and Western Blot as the validation approach.